New TB vaccine expected to fight drug-resistant TB bacteria

The Aeras Global TB Vaccine Foundation said at the Global Health International Conference in Washington, D.Cthey and their partners are developing a new generation of TB vaccine
hope to fight all types of drug-resistant TB bacteria,2007 there are six alternative new TB vaccinesor will be in phase I-2 clinical trials, andexpect spending the next seven to nine years on at least one new TB vaccine for newborns,for adolescentsThe new generation of TB vaccines will have a strong immunity against all types of TB bacteria, including MDR-TB, which is currently difficult to treat, and extensively drug-resistant tbMDR-TB and MDR-TB are new types of,more deadly TB emerging in recent years, especially MDR-TB, which is resistant to many of the current first- and second-line TB drugs, severely restricting drug options in the TB treatment process, Sadov saidAt least 37 countries around the world have reported cases of extensively drug-resistant tb, and the development of a new vaccine against drug-resistant TB has become a priorityThe current common TB vaccine, "Ka-Miao", has been around for more than 86 years and no other new TB vaccine has been developed since, Sadov saidCarmichael has a real effect on preventing children tuberculosis, but has limited effect on the prevention of more common lung tuberculosis A new generation of TB vaccines, combined with new TB drugs and diagnostic methods, will effectively reduce TB morbidity and mortality, Sadov said The Aeras Global TB Vaccine Foundation is currently the only non-profit organization in the world focused on developing a new TB vaccine It operates as a "
Drug Research and Development Partnership" and works with government health departments , private companies , medical research institutions and charitable organizations to develop new TB vaccines (
reprinted from "Xinhuanet")